Researchers Develop Potential Treatment For Deadliest Skin Cancer Using Modified Herpes Virus
Source: Euro Weekly News, August 2023
A new phase II clinical trial consisting of the use of a modified herpes virus has yielded favourable results for a strategy against melanoma.
This is the penultimate type of study that is required before a certain treatment can be approved for clinical use. In this instance, the American researchers were dealing with the deadliest form of skin cancer which can often prove to be fatal.
The authors of the work – Reinhard Dummer MD, David E. Gyorki MD, and John R. Hyngstrom MD – published their results in the specialised JAMA Network Open platform on August 10.